Patent Assignment
Reel/Frame 073304/0289
Assignment of Assignor's Interest
Recorded: 2025-12-23
Pages: 6
Assignor
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Executed: 2017-03-03
Assignees
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3160 CHESTNUT STREET, SUITE 200, PHILADELPHIA, PENNSYLVANIA, 19104
Covered Property
(1)
Treatment of Cancer Using Humanized Anti-CD19 Chimeric Antigen Receptor
Application:
17/132,674 →
Publication:
US 2021/0284752
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 15, 2022
From: BROGDON, JENNIFER; LOEW, ANDREAS
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 059265/0859 →
Assignment of Assignor's Interest
Mar 15, 2022
From: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
To: NOVARTIS AG
Reel/Frame 059265/0951 →
Assignment of Assignor's Interest
Mar 15, 2022
From: JUNE, CARL H.; MAUS, MARCELA; SCHOLLER, JOHN
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 059365/0651 →
Assignment of Assignor's Interest
Dec 23, 2025
From: NOVARTIS AG
To: NOVARTIS AG; THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 073304/0610 →